- COVID-19
- For Adolescents & Adults
What COVID-19 vaccine options are available for adolescents and adults ages 12 years and older?
Pfizer-BioNTech COVID-19 Vaccine (2024–2025 Formula), brand name Comirnaty, is FDA-licensed for a single dose in recipients age 12 years and older.
Moderna COVID-19 Vaccine (2024–2025 Formula), brand name Spikevax, is licensed for use in recipients age 12 years and older.
Novavax COVID-19 Vaccine (2024–2025 Formula) is authorized for emergency use as a 2-dose primary series or a single dose in previously vaccinated individuals age 12 years and older.
Last reviewed:
August 31, 2024